Quarterly report pursuant to Section 13 or 15(d)

Earnings per Share - Narrative (Details)

v3.24.1.u1
Earnings per Share - Narrative (Details) - shares
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Earnings Per Share [Abstract]    
Participating securities (in shares) 0 0
Anti-dilutive common stock equivalents (in shares) 143,000,000 162,000,000